WaveMan · Form 4
Heier Jeffrey S. insider trades
> Search tickers & screens ⌘K
LIVE

Heier Jeffrey S. insider trades

Heier Jeffrey S. has filed 17 Form 4s with the SEC that we hold, all for Ocular Therapeutix, INC (OCUL), as Chief Scientific Officer. Across all of them we count 1 purchase worth $45.8K and 10 sales worth $426.1K reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($204.0K). The largest single trade was a sale of 10,502 shares of Ocular Therapeutix, INC worth $115.9K, dated 2025-10-02. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-05-16 and the latest 2026-10-06.

Ocular Therapeutix, INC (OCUL)

Chief Scientific Officer · 17 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-05-12P, purchase reported on Form 415,000$45.8K2022-05-16
2024-11-25S, sale reported on Form 42,948$26.6K2024-11-27
2025-02-24S, sale reported on Form 43,061$21.0K2025-02-26
2025-05-23S, sale reported on Form 43,024$21.7K2025-05-27
2025-08-25S, sale reported on Form 43,063$36.9K2025-08-27
2025-10-02S, sale reported on Form 410,502$115.9K2025-10-06
2025-11-24S, sale reported on Form 43,469$41.8K2025-11-26
2026-02-23S, sale reported on Form 43,057$25.3K2026-02-25
2026-05-26S, sale reported on Form 43,018$24.7K2026-05-28
2026-08-24S, sale reported on Form 43,296$35.5K2026-08-26
2026-10-02S, sale reported on Form 410,869$76.6K2026-10-06
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1653082) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms